Elevation Oncology Inc (ELEV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,211 | -44,485 | -34,049 | -21,168 | -10,707 |
| Depreciation Amortization | -248 | -1,426 | -1,045 | -611 | -268 |
| Accounts payable and accrued liabilities | -67 | 52 | 2,125 | -163 | -72 |
| Other Working Capital | 642 | 3,839 | 4,514 | 840 | -605 |
| Other Operating Activity | 1,173 | 5,656 | 2,293 | 3,322 | 2,077 |
| Operating Cash Flow | $-12,711 | $-36,364 | $-26,162 | $-17,780 | $-9,575 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,758 | -8,365 | -19,833 | -16,960 | 20,700 |
| Investing Cash Flow | $23,758 | $-8,365 | $-19,833 | $-16,960 | $20,700 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 45,156 | 45,156 | 45,144 | 30,426 |
| Common Stock Repurchased | -17 | -48 | -44 | -42 | -26 |
| Other Financing Activity | 0 | -170 | -170 | -170 | -150 |
| Financing Cash Flow | $-17 | $44,938 | $44,942 | $44,932 | $30,250 |
| Beginning Cash Position | 49,464 | 49,255 | 49,255 | 49,255 | 49,255 |
| End Cash Position | 60,494 | 49,464 | 48,202 | 59,447 | 90,630 |
| Net Cash Flow | $11,030 | $209 | $-1,053 | $10,192 | $41,375 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,711 | -36,364 | -26,162 | -17,780 | -9,575 |
| Free Cash Flow | -12,711 | -36,364 | -26,162 | -17,780 | -9,575 |